Previously submitted to: JMIR Bioinformatics and Biotechnology (no longer under consideration since May 01, 2025)
Date Submitted: Nov 7, 2024
Open Peer Review Period: Nov 15, 2024 - Jan 10, 2025
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Identification of biomarkers related to autophagy in osteoarthritis via bioinformatics analysis and experimental validation
ABSTRACT
Background:
Osteoarthritis(OA) is a degenerative disease with few effective early interventions and therapeutic options, autophagy is thought to play a significant role in progression of OA.
Objective:
We used bioinformatics analysis and experimental validation to identify biomarkers related to autophagy in OA with the aim of therapeutic targets.
Methods:
The series matrix file GSE82107 was downloaded from Gene Expression Omnibus (GEO) public databases. The data were processed and differentially expressed genes (DEGs) were identified via R 4.2.2 software. The autophagy related-DEGs were subsequently defined as DEGs from GSE82107 that overlapped with autophagy-related genes and were subsequently selected on the basis of a Venn diagram. The autophagy related-DEGs were screened via Gene Ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis, protein-protein interaction (PPI) analysis and immune cell infiltration analysis. Based on the constructed PPI network, the hub genes were identified via the CytoHubba plugin. Moreover, the hub genes were confirmed via the receiver operating characteristic (ROC) curve analysis of the GSE129147 and GSE169077 datasets. In addition, we collected synovial tissue from the knees of ten patients: five OA patients who underwent total knee arthroplasty and five young patients who underwent arthroscopic surgery for anterior cruciate ligament rupture. The collected synovial samples were subjected to RNA extraction followed by real-time quantitative RT-PCR.Finally, we verified the expression of the HUB gene by calculating the corresponding mRNA expression levels.
Results:
Five genes namely, BCL2L1, CTSD, ATG3, GABARAPL2 and CTSB were identified as hub autophagy related-DEGs. ROC analysis revealed that almost all the hub genes had good diagnostic value, but by the Q-PCR results of the clinical samples revealed that BCL2L1, GABARAPL2, and CTSB were all upregulated in OA (p < 0.05). The relative expressions of CTSD and ATG3 were not significantly different between the OA group and the control group (p > 0.05).
Conclusions:
This study identified hub genes related to autophagy in OA, including BCL2L1, GABARAPL2, and CTSB. These genes are promising targets for OA treatment.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.